(1)
Iqbal, F. Enhancing the Effectiveness of Chimeric Antigen Receptor (CAR) T Cells Against Tumors through CRISPR/Cas9-Mediated PD-1 Disruption. Int. J. of Health Sci. 2023, 7, 1836-1850.